Eloxatin

In the US, Eloxatin (oxaliplatin systemic) is a member of the drug class alkylating agents and is used to treat Colorectal Cancer.

US matches:

• Eloxatin

UK matches:

• Eloxatin 5 mg/ml concentrate for solution for infusion (SPC)

Ingredient matches for Eloxatin

Oxaliplatin

Oxaliplatin is reported as an ingredient of Eloxatin in the following countries:

• Antigua & Barbuda


• Australia


• Austria


• Bahamas


• Bahrain


• Barbados


• Belgium


• Bermuda


• Brazil


• Bulgaria


• Canada


• Cayman Islands


• Chile


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Dominican Republic


• Ecuador


• Egypt


• El Salvador


• Estonia


• Finland


• Germany


• Greece


• Guatemala


• Guyana


• Haiti


• Honduras


• Hong Kong


• Hungary


• Indonesia


• Iran


• Iraq


• Israel


• Italy


• Jamaica


• Jordan


• Kuwait


• Latvia


• Lebanon


• Lithuania


• Luxembourg


• Malaysia


• Malta


• Mexico


• Netherlands


• Netherlands Antilles


• New Zealand


• Nicaragua


• Norway


• Oman


• Panama


• Peru


• Poland


• Portugal


• Qatar


• Romania


• Saint Lucia


• Saint Vincent & The Grenadines


• Saudi Arabia


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Syria


• Taiwan


• Thailand


• Trinidad & Tobago


• Turkey


• United Arab Emirates


• United Kingdom


• United States


• Venezuela


• Vietnam


• Yemen

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.